DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Rajgor Castor Derivatives Limited — Committee Meeting Updates

NSE 3 hrs ago·18 Aug 2026, 12:53 pm

Company NSE

Rajgor Castor Derivatives Limited has announced that its Right Issue Committee met on August 18, 2026, to review the progress of its proposed rights issue. This meeting was held to assess the current status and finalize the necessary steps for the capital raising exercise.

The announcement is a routine update for investors, as it signals that the company is actively working towards executing its capital raising plan. For retail investors, this news is neutral and does not yet indicate a specific outcome or timeline for the issue itself.

Investors should keep an eye on the company's subsequent filings for the final terms of the rights issue, including the price and record date. This information will be crucial for shareholders to understand their entitlements and decide whether to participate in the offer.